Enhancing Lifestyles in the Metabolic syndrome (ELM) multisite behavioral efficacy trial. Design and baseline cohort
Study context
- Population
- US adults with metabolic syndrome (MetS)14,817 screened
- Participants
- 618 adults
- Comparison
- Habit-based small group lifestyle treatment vs enhanced standard of care education
- Primary endpoint
- MetS remission
- Follow-up
- 24 months
Methodological detailsmultisite (5 US sites), individually randomized, partially clustered group treatment trial, behavioral efficacy trial
- Multisite (5 US sites)
- Individually randomized, partially clustered group treatment trial
- Behavioral efficacy trial
Primary result
As reported in the abstract
Baseline cohort characteristics
- Mean age
- 55.5 years
- Male
- 24.3%
- Racial minority
- 25.5%
- Hispanic
- 9.7%
- Obese (BMI >30)
- 83.0%
- Abdominal obesity
- 97.7%
- Elevated BP or antihypertensive medication
- 86.2%
- Screening to enrollment ratio
- 24:1
Original publication
Enhancing Lifestyles in the Metabolic syndrome (ELM) multisite behavioral efficacy trial. Design and baseline cohort. Am Heart J. Published 10 January 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →